BLCO
Bausch + Lomb Corporation
BLCO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
BLCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
BLCO's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
BLCO PE Valuation
BLCO has no meaningful PE right now: it lost money over the past year.
BLCO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BLCO, with profitability improving. However, they disagree widely on these estimates.
BLCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.17 | — |
| Q3 2026 | -$0.31 | +$0.55 |
| Q2 2026 | -$0.48 | +$0.29 |
| Q1 2026 | -$0.62 | +$0.40 |
| Q4 2025 | -$1.02 | -$0.12 |
| Q3 2025 | -$0.86 | +$0.19 |
| Q2 2025 | -$0.77 | +$0.53 |
| Q1 2025 | -$1.02 | -$0.06 |
| Q4 2024 | -$0.90 | -$0.16 |
BLCO is still losing money, but far less than before: $0.31 per share over the past year, against $1.30 at its worst in mid-2024.
BLCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +7.3% |
| Q2 2026 | $1.4B | +9.1% |
| Q1 2026 | $1.2B | +9.4% |
| Q4 2025 | $1.4B | +9.8% |
| Q3 2025 | $1.3B | +7.1% |
| Q2 2025 | $1.3B | +5.1% |
| Q1 2025 | $1.1B | +3.5% |
| Q4 2024 | $1.3B | +9.1% |
BLCO's revenue has grown year over year for 15 quarters in a row: $1.4B last quarter, up 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.8 points |
| Q2 2026 | 6% | +6.8 points |
| Q1 2026 | 2.6% | +9.9 points |
| Q4 2025 | 8% | +1.2 points |
| Q3 2025 | 7.4% | +3.8 points |
| Q2 2025 | -0.9% | -3 points |
| Q1 2025 | -7.3% | -7.8 points |
| Q4 2024 | 6.8% | +2.6 points |
BLCO's operating margin was 11% last quarter, up 3.8 points from the same quarter a year ago, near the top of its range since 2020.
BLCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $178M | +183% |
| Q2 2026 | $82M | +$136M |
| Q1 2026 | -$68M | +$67M |
| Q4 2025 | $60M | +$130M |
| Q3 2025 | $63M | -33% |
| Q2 2025 | -$54M | +$3M |
| Q1 2025 | -$135M | -$109M |
| Q4 2024 | -$70M | -$1M |
BLCO's free cash flow has turned positive after four years mostly in the red: $252M over the past year.
BLCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.7x | High |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.7x | High |
| Q3 2025 | 9.0x | High |
| Q2 2025 | 10.1x | High |
| Q1 2025 | 9.2x | High |
| Q4 2024 | 7.5x | High |
BLCO's net debt is about 5.7 years of its operating earnings (EBITDA), down from 9.0 years a year ago.
BLCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.1 | Overbought |
| Stochastic | 83.1 | Overbought |
BLCO's weekly RSI is 73 (overbought) and its Stochastic is 83 (overbought).
BLCO PE vs Healthcare Sector
| Metric | BLCO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BLCO has no meaningful PE right now: it lost money over the past year.
BLCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.3 | 16% above |
| 20 week MA | $17.5 | 21% above |
| 50 week MA | $16.9 | 25% above |
| 100 week MA | $15.7 | 34% above |
| 200 week MA | $16.4 | 29% above |
BLCO has climbed back above all five of its weekly moving averages, and it's now 29% above its 200-week average.
BLCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.0 | $14.6 | -27% |
| 2023 | $14.6 | $17.1 | +17% |
| 2024 | $17.1 | $18.0 | +5.3% |
| 2025 | $18.0 | $17.2 | -4.4% |
| 2026 YTD | $17.2 | $21.1 | +23% |
BLCO has finished lower in two of the last four years. It's up 23% so far in 2026.